ArticleDrug, healthcare and patient safety2026
Design and Evaluation of a Gamification-Based Mobile Application for Reporting Adverse Drug Reactions by Patients and Healthcare Professionals: A Pilot Usability Study in Diabetes Care.
Article in Drug, healthcare and patient safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adverse drug reactions (ADRs) represent a significant challenge in pharmacovigilance, particularly for patients with chronic conditions like diabetes. Traditional reporting methods are often cumbersome and suffer from substantial underreporting. Mobile health applications with gamification elements offer a promising approach to enhance ADR reporting engagement. Objective: This study aimed to design, develop, and evaluate a gamified mobile application (RxFeedback) for ADR reporting among diabetic patients and healthcare professionals in Iran, with gamification mechanics (points, leaderboards, challenges) as the core engagement strategy. Methods: This analytical cross-sectional pilot study employed a user-centered design methodology in three phases: 1) Requirements gathering through literature review and stakeholder surveys (5 patients, 4 professionals); 2) Application development using Flutter framework with Dart programming language for Android platform; 3) Evaluation using Mobile Application Rating Scale (MARS) by 5 experts and Questionnaire for User Interaction Satisfaction (QUIS) by 20 patients. Results: The RxFeedback application incorporated comprehensive ADR reporting features, medication management, and gamification elements (points system, leaderboards, challenges). Expert evaluation yielded a mean MARS score of 3.65/5, with highest scores in functionality (4.05) and lowest in aesthetics (3.40). Patient satisfaction assessment showed an overall QUIS score of 6.14/10, with highest satisfaction in application features (6.8) and lowest in terminology (5.7), though the limited sample size (n=20 patients, n=5 experts) and focus on usability should be noted as preliminary study constraints. Conclusion: RxFeedback demonstrated acceptable usability and quality (MARS: 3.65/5; QUIS: 6.14/10) in this pilot study. However, effectiveness in improving actual ADR reporting rates was not assessed. These findings establish preliminary acceptability as a foundation for future experimental studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.